Linkage of Ii-Key segment to gp100(46-58) epitope enhances the production of epitope-specific antibodies

Vaccine

Volumn 23, Issue 17-18, 2005, Pages 2336-2338

  Kallinteris, Nikoletta L ^a   Wu, Shuzhen ^a   Lu, Xueqing ^a   Von Hofe, Eric ^a   Humphreys, Robert E ^a   Xu, Minzhen ^a  

^a Antigen Express Inc   (United States)

Author keywords

gp100(46 58); Ii Key segment; MHC

Indexed keywords

ARGINYLGLUTAMINYLLEUCYLTYROSYLPROLYLGLUTAMYLTRYPTOPHYLTHREONYLGLUTAMYL ALANYLGLUTAMINYLARGINYLLEUCINE; ASPARAGINYLARGINYLGLUTAMINYLLEUCYLTYROSYLPROLYLGLUTAMYLTRYPTOPHYLTHREONYL GLUTAMYLALANYLGLUTAMINYLARGINYLLEUCINE; GLUTAMINYLLEUCYLTYROSYLPROLYLGLUTAMYLTRYPTOPHYLTHREONYLGLUTAMYLALANYL GLUTAMINYLARGINYLLEUCINE; GLYCOPROTEIN GP 100; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; LEUCYLTYROSYLPROLYLGLUTAMYLTRYPTOPHYLTHREONYLGLUTAMYLALANYLGLUTAMINYL ARGINYLLEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 14844293066     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.038     Document Type: Conference Paper

References (11)

1. M. Xu, R. Jackson, S. Adams, and R.E. Humphreys Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1 Arzneimittelforschung 49 1999 791 799
2. R.E. Humphreys, S. Adams, G. Koldzic, B. Nedelescu, E. von Hofe, and M. Xu Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide Vaccine 18 2000 2693 2697
3. N.L. Kallinteris, X. Lu, S. Wu, Kallinteris, H. Hu, and Y. Li Ii-Key/MHC class II epitope hybrid peptide vaccines for HIV Vaccine 21 2003 4128 4132
4. M.E. Gillogly, N.L. Kallinteris, M. Xu, J.V. Gulfo, R.E. Humphreys, and J.L. Murray Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer Cancer Immunol Immunother 53 2004 490 496
5. K. Ito, H.J. Bian, M. Molina, J. Han, J. Magram, and E. Saar HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis J. Exp. Med. 183 1996 2635 2644
6. C.E. Touloukian, W.W. Leitner, S.L. Topalian, Y.F. Li, P.F. Robbins, and S.A. Rosenberg Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice J Immunol 164 2000 3535 3542
7. P. Victoratos, M. Yiangou, N. Avramidis, and L. Hadjipetrou Regulation of cytokine gene expression by adjuvants in vivo Clin Exp Immunol 109 1997 569 578
8. B.S. Fox Antibody responses to a cytochrome c peptide do not correlate with lymphokine production patterns from helper T-cell subsets Immunology 75 1992 164 169
9. H.C. Yip, A.Y. Karulin, M. Tary-Lehmann, M.D. Hesse, H. Radeke, and P.S. Heeger Adjuvant guided type 1 and type 2 immunity: infectious/non-infectious dichotomy defines the class of response J Immunol 162 1999 3942 3949
10. N. Liu, N. Ohnishi, L. Ni, S. Akira, and K.B. Bacon CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells Nat Immunol 4 2003 687 693
11. S.R. Paludan Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship Scand J Immunol 48 1998 459 468